tagitanlimab

Home
Ligands
tagitanlimab

GtoPdb Ligand ID: 13795

Synonyms: A-167 | Cotelet® | HBM-9167 | KL-A167 | KLA167

tagitanlimab is an approved drug

Comment: Tagitanlimab (KL-A167) is a humanized anti-programmed cell death-ligand 1 (PD-L1) monoclonal antibody [1]. It is designed to block the inhibitory PD-1/PD-L1 immune checkpoint and restore anti-tumour immunity.

Summary
Biological activity
Clinical data
References
Immunopharmacology

Immunopharmacology Comments
Tagitanlimab is an immune checkpoint inhibitor. It blocks the inhibitory PD-1/PD-L1 immune checkpoint and restores T cell-mediated anti-tumour immunity.

Immunopharmacology Comments

Tagitanlimab is an immune checkpoint inhibitor. It blocks the inhibitory PD-1/PD-L1 immune checkpoint and restores T cell-mediated anti-tumour immunity.